

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.07214673 |
| 2 | positive regulation of histone deacetylation (GO:0031065) | 3.97287221 |
| 3 | growth hormone receptor signaling pathway (GO:0060396) | 3.93930097 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.93047445 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 3.93047445 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91397112 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87819322 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86396669 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86396669 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.86396669 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86396669 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.86396669 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86396669 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.76778084 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.76778084 |
| 16 | mannose metabolic process (GO:0006013) | 3.67836736 |
| 17 | response to peptidoglycan (GO:0032494) | 3.66908386 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66213097 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.63745702 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62461001 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.57668447 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.51240015 |
| 23 | negative regulation of cell killing (GO:0031342) | 3.47245096 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.47245096 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 3.43124225 |
| 26 | cellular response to growth hormone stimulus (GO:0071378) | 3.38256582 |
| 27 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.33029356 |
| 28 | protein localization to endosome (GO:0036010) | 3.32363116 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.31684679 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.31509616 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28912659 |
| 32 | detection of other organism (GO:0098543) | 3.20957779 |
| 33 | detection of bacterium (GO:0016045) | 3.19386415 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.18792856 |
| 35 | protein carboxylation (GO:0018214) | 3.18511630 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.18511630 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.14614759 |
| 38 | germinal center formation (GO:0002467) | 3.08988402 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.08254911 |
| 40 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.06691035 |
| 41 | positive regulation of lipid catabolic process (GO:0050996) | 3.04411444 |
| 42 | maternal placenta development (GO:0001893) | 3.04054534 |
| 43 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03840308 |
| 44 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.03821809 |
| 45 | regulation of leukocyte degranulation (GO:0043300) | 3.03294274 |
| 46 | regulation of cholesterol storage (GO:0010885) | 3.03142834 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 2.99588461 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 2.98927824 |
| 49 | lysine catabolic process (GO:0006554) | 2.98884811 |
| 50 | lysine metabolic process (GO:0006553) | 2.98884811 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 2.98324207 |
| 52 | glyoxylate metabolic process (GO:0046487) | 2.96010083 |
| 53 | kynurenine metabolic process (GO:0070189) | 2.95906830 |
| 54 | urea cycle (GO:0000050) | 2.95438036 |
| 55 | urea metabolic process (GO:0019627) | 2.95438036 |
| 56 | barbed-end actin filament capping (GO:0051016) | 2.95256965 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 2.94940492 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94610168 |
| 59 | modulation by symbiont of host cellular process (GO:0044068) | 2.93477459 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 2.93462084 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88862712 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 2.88537878 |
| 63 | positive regulation of fatty acid oxidation (GO:0046321) | 2.88253805 |
| 64 | leukocyte aggregation (GO:0070486) | 2.88057627 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86474668 |
| 66 | thymic T cell selection (GO:0045061) | 2.86025239 |
| 67 | negative regulation of sterol transport (GO:0032372) | 2.85835341 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 2.85835341 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 2.85112692 |
| 70 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.85112443 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.84253154 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83360669 |
| 73 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.82626600 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 2.81668058 |
| 75 | modulation by virus of host process (GO:0019054) | 2.81010287 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.79968412 |
| 77 | complement activation, alternative pathway (GO:0006957) | 2.79849770 |
| 78 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.78056462 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 2.77840793 |
| 80 | protein-lipid complex assembly (GO:0065005) | 2.76613059 |
| 81 | regulation of p38MAPK cascade (GO:1900744) | 2.76162933 |
| 82 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.75244154 |
| 83 | creatine metabolic process (GO:0006600) | 2.75044030 |
| 84 | signal complex assembly (GO:0007172) | 2.74394932 |
| 85 | bile acid biosynthetic process (GO:0006699) | 2.74026263 |
| 86 | phospholipid efflux (GO:0033700) | 2.72577665 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 2.72045734 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 2.71969881 |
| 89 | nitrogen cycle metabolic process (GO:0071941) | 2.71536019 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70266454 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70165645 |
| 92 | glutamate metabolic process (GO:0006536) | 2.70068281 |
| 93 | cysteine metabolic process (GO:0006534) | 2.69864621 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68625466 |
| 95 | detection of external biotic stimulus (GO:0098581) | 2.67882734 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 2.65806810 |
| 97 | sodium ion export (GO:0071436) | 2.63650846 |
| 98 | stress fiber assembly (GO:0043149) | 2.63081670 |
| 99 | regulation of fatty acid oxidation (GO:0046320) | 2.63039427 |
| 100 | response to growth hormone (GO:0060416) | 2.62466173 |
| 101 | regulation of fibrinolysis (GO:0051917) | 2.62129301 |
| 102 | activation of MAPKKK activity (GO:0000185) | 2.61527013 |
| 103 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.61368465 |
| 104 | ethanol oxidation (GO:0006069) | 2.61097552 |
| 105 | glycosphingolipid catabolic process (GO:0046479) | 2.60230674 |
| 106 | regulation of regulated secretory pathway (GO:1903305) | 2.59999668 |
| 107 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59708183 |
| 108 | negative regulation of cell size (GO:0045792) | 2.59244527 |
| 109 | cholesterol efflux (GO:0033344) | 2.59018178 |
| 110 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.58484414 |
| 111 | amino sugar catabolic process (GO:0046348) | 2.58380978 |
| 112 | adenosine receptor signaling pathway (GO:0001973) | 2.58045987 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57554903 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 2.57554903 |
| 115 | macromolecular complex remodeling (GO:0034367) | 2.57554903 |
| 116 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56838287 |
| 117 | positive thymic T cell selection (GO:0045059) | 2.56103364 |
| 118 | T cell selection (GO:0045058) | 2.54091580 |
| 119 | regulation of ARF GTPase activity (GO:0032312) | 2.52926498 |
| 120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52191656 |
| 121 | phospholipid homeostasis (GO:0055091) | 2.51557773 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51251640 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.50962625 |
| 124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50794375 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.50415408 |
| 126 | positive regulation of protein deacetylation (GO:0090312) | 2.50283180 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49124975 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49098888 |
| 129 | response to host immune response (GO:0052572) | 2.49098888 |
| 130 | positive regulation of protein dephosphorylation (GO:0035307) | 2.48218335 |
| 131 | reverse cholesterol transport (GO:0043691) | 2.48165128 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.48127384 |
| 133 | fatty acid transmembrane transport (GO:1902001) | 2.47954201 |
| 134 | amino-acid betaine metabolic process (GO:0006577) | 2.47436092 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47291238 |
| 136 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.46163240 |
| 137 | regulation of triglyceride metabolic process (GO:0090207) | 2.45961754 |
| 138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44872685 |
| 139 | triglyceride homeostasis (GO:0070328) | 2.44627610 |
| 140 | acylglycerol homeostasis (GO:0055090) | 2.44627610 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.44221966 |
| 142 | B cell receptor signaling pathway (GO:0050853) | 2.43779956 |
| 143 | regulation of protein activation cascade (GO:2000257) | 2.43631123 |
| 144 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43590072 |
| 145 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42080990 |
| 146 | response to host (GO:0075136) | 2.42080990 |
| 147 | response to host defenses (GO:0052200) | 2.42080990 |
| 148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.41851552 |
| 149 | regulation of defense response to virus by virus (GO:0050690) | 2.40895474 |
| 150 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.40653214 |
| 151 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.40614610 |
| 152 | regulation of lipid catabolic process (GO:0050994) | 2.40575161 |
| 153 | aspartate family amino acid catabolic process (GO:0009068) | 2.39966433 |
| 154 | regulation of superoxide anion generation (GO:0032928) | 2.39007643 |
| 155 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.38739084 |
| 156 | negative regulation of heart growth (GO:0061117) | 2.38739084 |
| 157 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38319319 |
| 158 | negative regulation of lipid transport (GO:0032369) | 2.37585473 |
| 159 | positive regulation of lipid storage (GO:0010884) | 2.37473209 |
| 160 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37331620 |
| 161 | myeloid cell activation involved in immune response (GO:0002275) | 2.37076875 |
| 162 | cholesterol homeostasis (GO:0042632) | 2.36796068 |
| 163 | positive T cell selection (GO:0043368) | 2.36469104 |
| 164 | negative regulation of innate immune response (GO:0045824) | 2.36437544 |
| 165 | tolerance induction (GO:0002507) | 2.36170913 |
| 166 | sterol homeostasis (GO:0055092) | 2.36152525 |
| 167 | pinocytosis (GO:0006907) | 2.35340351 |
| 168 | detection of biotic stimulus (GO:0009595) | 2.34661302 |
| 169 | detection of molecule of bacterial origin (GO:0032490) | 2.34427436 |
| 170 | protein-lipid complex subunit organization (GO:0071825) | 2.34253502 |
| 171 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.34137293 |
| 172 | cellular extravasation (GO:0045123) | 2.33909456 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.33003871 |
| 174 | macrophage activation (GO:0042116) | 2.32068664 |
| 175 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.32064719 |
| 176 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.32054430 |
| 177 | bile acid metabolic process (GO:0008206) | 2.31926769 |
| 178 | activation of JUN kinase activity (GO:0007257) | 2.31243260 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.31030352 |
| 180 | positive regulation of Rap GTPase activity (GO:0032854) | 2.30812704 |
| 181 | positive regulation of receptor recycling (GO:0001921) | 2.30793209 |
| 182 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.30763172 |
| 183 | cellular ketone body metabolic process (GO:0046950) | 2.30641045 |
| 184 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.30341904 |
| 185 | glycolipid catabolic process (GO:0019377) | 2.29772808 |
| 186 | acetyl-CoA metabolic process (GO:0006084) | 2.29350066 |
| 187 | apoptotic process involved in morphogenesis (GO:0060561) | 2.28617427 |
| 188 | cortical actin cytoskeleton organization (GO:0030866) | 2.28580554 |
| 189 | regulation of complement activation (GO:0030449) | 2.27833992 |
| 190 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27521377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.61778151 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.55839572 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.29061218 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25376766 |
| 5 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.73192400 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71739014 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68946399 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.68244086 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.64554791 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.60100894 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59141768 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.58949828 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38568791 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27013678 |
| 15 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21564189 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.21366193 |
| 17 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.12669327 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09173053 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01963851 |
| 20 | KDM2B_26808549_Chip-Seq_K562_Human | 1.94806998 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.91324385 |
| 22 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.88318353 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83033942 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81529969 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80601114 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77137574 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76022395 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71982189 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69572049 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69149396 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66969823 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65365256 |
| 33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54062792 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52165169 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52048127 |
| 36 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51282239 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50889749 |
| 38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50262199 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.48687126 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48574854 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46944921 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45693004 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44030177 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43231456 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42971892 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41084607 |
| 47 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.40969687 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38705152 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38625343 |
| 50 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38499406 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38068756 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37678888 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36568027 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35894120 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34354065 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31814365 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31569010 |
| 58 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31527373 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.31269656 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30936537 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30670260 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29953386 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29282221 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29157337 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28528214 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28219581 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28178822 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27113774 |
| 69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27056833 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27056833 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25408413 |
| 72 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23992534 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.23546135 |
| 74 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23541691 |
| 75 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22331895 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22024980 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21007882 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20740169 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20172675 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19537566 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19163645 |
| 82 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18681720 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18545231 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18454361 |
| 85 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18110354 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15296549 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14758053 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14568167 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12652128 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10021268 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09800350 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09187431 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09023205 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08408626 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07775731 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07323215 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07063833 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06973267 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06956396 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05207567 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05154379 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05103086 |
| 103 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04490779 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03222537 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02538649 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02311919 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01594056 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01076117 |
| 109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00428422 |
| 110 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00292842 |
| 111 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99686591 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99372624 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99174897 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98473675 |
| 115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98265208 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98187753 |
| 117 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97348560 |
| 118 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97313787 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96948240 |
| 120 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96248894 |
| 121 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96232464 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95329706 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94391651 |
| 124 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93891876 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92636046 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91758271 |
| 127 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91677997 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91381427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.19325633 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.98547382 |
| 3 | MP0003303_peritoneal_inflammation | 3.82346194 |
| 4 | MP0009840_abnormal_foam_cell | 3.34465151 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.09221724 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.08379402 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.08266393 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.94757403 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.85266864 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.81493141 |
| 11 | MP0005365_abnormal_bile_salt | 2.80000411 |
| 12 | MP0005083_abnormal_biliary_tract | 2.54460836 |
| 13 | MP0003252_abnormal_bile_duct | 2.29770573 |
| 14 | MP0003724_increased_susceptibility_to | 2.22156035 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.21666665 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.16165116 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.15623322 |
| 18 | MP0004510_myositis | 2.08190750 |
| 19 | MP0004130_abnormal_muscle_cell | 2.04171860 |
| 20 | MP0008260_abnormal_autophagy | 2.02672517 |
| 21 | MP0005671_abnormal_response_to | 1.91974109 |
| 22 | MP0005666_abnormal_adipose_tissue | 1.84596243 |
| 23 | MP0008961_abnormal_basal_metabolism | 1.78731262 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.77082964 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.74008789 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.72063147 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.71844047 |
| 28 | MP0000685_abnormal_immune_system | 1.67916378 |
| 29 | MP0000609_abnormal_liver_physiology | 1.66781131 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.63145915 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.62807584 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.61221900 |
| 33 | MP0009785_altered_susceptibility_to | 1.59937681 |
| 34 | MP0003075_altered_response_to | 1.56543470 |
| 35 | MP0003436_decreased_susceptibility_to | 1.55208534 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.52861125 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.51681527 |
| 38 | MP0009278_abnormal_bone_marrow | 1.51249921 |
| 39 | MP0000858_altered_metastatic_potential | 1.46365336 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.42172027 |
| 41 | MP0005330_cardiomyopathy | 1.41481777 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.38956892 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.37719979 |
| 44 | MP0006082_CNS_inflammation | 1.36403541 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.33474106 |
| 46 | MP0003828_pulmonary_edema | 1.32712244 |
| 47 | MP0000343_altered_response_to | 1.32391802 |
| 48 | MP0000716_abnormal_immune_system | 1.29819966 |
| 49 | MP0001849_ear_inflammation | 1.29564081 |
| 50 | MP0002398_abnormal_bone_marrow | 1.27979232 |
| 51 | MP0003879_abnormal_hair_cell | 1.27745002 |
| 52 | MP0005387_immune_system_phenotype | 1.26153730 |
| 53 | MP0001790_abnormal_immune_system | 1.26153730 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.26059956 |
| 55 | MP0005332_abnormal_amino_acid | 1.24762229 |
| 56 | MP0002971_abnormal_brown_adipose | 1.24194394 |
| 57 | MP0003690_abnormal_glial_cell | 1.23846928 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.23823685 |
| 59 | MP0000604_amyloidosis | 1.23079548 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.21533608 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.20713228 |
| 62 | MP0010630_abnormal_cardiac_muscle | 1.20371122 |
| 63 | MP0000751_myopathy | 1.20079719 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18467431 |
| 65 | MP0005670_abnormal_white_adipose | 1.16369931 |
| 66 | MP0003091_abnormal_cell_migration | 1.16294588 |
| 67 | MP0005451_abnormal_body_composition | 1.14570020 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.14433927 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.13012552 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.13012552 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.12971923 |
| 72 | MP0005310_abnormal_salivary_gland | 1.11899708 |
| 73 | MP0004381_abnormal_hair_follicle | 1.08946183 |
| 74 | MP0001873_stomach_inflammation | 1.07566942 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.06999617 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.05416596 |
| 77 | MP0004859_abnormal_synaptic_plasticity | 1.04506826 |
| 78 | MP0002429_abnormal_blood_cell | 1.04416874 |
| 79 | MP0008874_decreased_physiological_sensi | 1.02597547 |
| 80 | MP0003566_abnormal_cell_adhesion | 1.00923771 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.99707383 |
| 82 | MP0002722_abnormal_immune_system | 0.99635135 |
| 83 | MP0001800_abnormal_humoral_immune | 0.97959438 |
| 84 | MP0005409_darkened_coat_color | 0.97784922 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.97494118 |
| 86 | MP0003866_abnormal_defecation | 0.97322311 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.96270391 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.95026912 |
| 89 | MP0003646_muscle_fatigue | 0.94192635 |
| 90 | MP0000747_muscle_weakness | 0.93388294 |
| 91 | MP0000598_abnormal_liver_morphology | 0.92742494 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.92659685 |
| 93 | MP0005025_abnormal_response_to | 0.90440676 |
| 94 | MP0003448_altered_tumor_morphology | 0.89431894 |
| 95 | MP0002933_joint_inflammation | 0.88484120 |
| 96 | MP0005385_cardiovascular_system_phenoty | 0.88266512 |
| 97 | MP0001544_abnormal_cardiovascular_syste | 0.88266512 |
| 98 | MP0003329_amyloid_beta_deposits | 0.88260972 |
| 99 | MP0004858_abnormal_nervous_system | 0.87677028 |
| 100 | MP0003634_abnormal_glial_cell | 0.86974575 |
| 101 | MP0004036_abnormal_muscle_relaxation | 0.86671146 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.86046045 |
| 103 | MP0008469_abnormal_protein_level | 0.84344806 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.84189308 |
| 105 | MP0005334_abnormal_fat_pad | 0.82944981 |
| 106 | MP0005390_skeleton_phenotype | 0.82618810 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.82492414 |
| 108 | MP0003011_delayed_dark_adaptation | 0.82010997 |
| 109 | MP0004947_skin_inflammation | 0.81578016 |
| 110 | MP0009764_decreased_sensitivity_to | 0.81362192 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.80963834 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.80638466 |
| 113 | MP0001663_abnormal_digestive_system | 0.79509483 |
| 114 | MP0005166_decreased_susceptibility_to | 0.79455471 |
| 115 | MP0003868_abnormal_feces_composition | 0.79332186 |
| 116 | MP0003279_aneurysm | 0.78606187 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.78248762 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.77935497 |
| 119 | MP0002419_abnormal_innate_immunity | 0.77464344 |
| 120 | MP0002723_abnormal_immune_serum | 0.77443672 |
| 121 | MP0000749_muscle_degeneration | 0.77398824 |
| 122 | MP0002796_impaired_skin_barrier | 0.76586680 |
| 123 | MP0000759_abnormal_skeletal_muscle | 0.76412058 |
| 124 | MP0009763_increased_sensitivity_to | 0.75406797 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.75070178 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.74171218 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.73828730 |
| 128 | MP0008569_lethality_at_weaning | 0.72554567 |
| 129 | MP0002269_muscular_atrophy | 0.72028043 |
| 130 | MP0005165_increased_susceptibility_to | 0.72009531 |
| 131 | MP0000920_abnormal_myelination | 0.71691342 |
| 132 | MP0002970_abnormal_white_adipose | 0.71468023 |
| 133 | MP0008004_abnormal_stomach_pH | 0.70227798 |
| 134 | MP0003045_fibrosis | 0.69691554 |
| 135 | MP0000249_abnormal_blood_vessel | 0.69550819 |
| 136 | MP0010234_abnormal_vibrissa_follicle | 0.69330478 |
| 137 | MP0002420_abnormal_adaptive_immunity | 0.68506796 |
| 138 | MP0002106_abnormal_muscle_physiology | 0.68478411 |
| 139 | MP0002972_abnormal_cardiac_muscle | 0.67824405 |
| 140 | MP0003795_abnormal_bone_structure | 0.67660676 |
| 141 | MP0001819_abnormal_immune_cell | 0.67585352 |
| 142 | MP0000733_abnormal_muscle_development | 0.66649938 |
| 143 | MP0009115_abnormal_fat_cell | 0.66091945 |
| 144 | MP0002405_respiratory_system_inflammati | 0.65075273 |
| 145 | MP0002254_reproductive_system_inflammat | 0.64983785 |
| 146 | MP0001853_heart_inflammation | 0.64759247 |
| 147 | MP0006138_congestive_heart_failure | 0.64017583 |
| 148 | MP0001851_eye_inflammation | 0.63482308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.58631079 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77317140 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77317140 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77317140 |
| 5 | Xanthomatosis (HP:0000991) | 3.74577372 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.55449288 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33454010 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.29161968 |
| 9 | Complement deficiency (HP:0004431) | 3.21492362 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.21014682 |
| 11 | Abnormality of the Achilles tendon (HP:0005109) | 3.16829476 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.10965625 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.02256386 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.99866381 |
| 15 | Achilles tendon contracture (HP:0001771) | 2.97778993 |
| 16 | Myocardial infarction (HP:0001658) | 2.87874315 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 2.86701545 |
| 18 | Polycythemia (HP:0001901) | 2.86659023 |
| 19 | Abnormality of complement system (HP:0005339) | 2.81535735 |
| 20 | Ketosis (HP:0001946) | 2.79313760 |
| 21 | Joint hemorrhage (HP:0005261) | 2.75013709 |
| 22 | Sudden death (HP:0001699) | 2.72975902 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70719613 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.70676726 |
| 25 | Loss of speech (HP:0002371) | 2.68816990 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.68000479 |
| 27 | Purpura (HP:0000979) | 2.66706285 |
| 28 | Hepatoblastoma (HP:0002884) | 2.64866776 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 2.62667138 |
| 30 | Ketoacidosis (HP:0001993) | 2.62658837 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.58719237 |
| 32 | Myositis (HP:0100614) | 2.51487404 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50214434 |
| 34 | Obstructive lung disease (HP:0006536) | 2.50214434 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.49691120 |
| 36 | Ventricular tachycardia (HP:0004756) | 2.49316278 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46427183 |
| 38 | Hypercholesterolemia (HP:0003124) | 2.45497618 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.44806626 |
| 40 | Neonatal hypoglycemia (HP:0001998) | 2.44298500 |
| 41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42931614 |
| 42 | Increased IgE level (HP:0003212) | 2.41809878 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 2.39524800 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.39050734 |
| 45 | Axonal loss (HP:0003447) | 2.35442494 |
| 46 | Orchitis (HP:0100796) | 2.34462424 |
| 47 | Gingivitis (HP:0000230) | 2.33023507 |
| 48 | Myoglobinuria (HP:0002913) | 2.30416155 |
| 49 | Hyperammonemia (HP:0001987) | 2.30022422 |
| 50 | Meningitis (HP:0001287) | 2.28238654 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.27142488 |
| 52 | Amyloidosis (HP:0011034) | 2.21174758 |
| 53 | Exercise-induced myalgia (HP:0003738) | 2.20344882 |
| 54 | Reticulocytosis (HP:0001923) | 2.19887405 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.19839021 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.19153697 |
| 57 | Late onset (HP:0003584) | 2.19048244 |
| 58 | Verrucae (HP:0200043) | 2.18317250 |
| 59 | Papilloma (HP:0012740) | 2.18317250 |
| 60 | Cellulitis (HP:0100658) | 2.15367908 |
| 61 | Increased connective tissue (HP:0009025) | 2.15155020 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.14533101 |
| 63 | Skin nodule (HP:0200036) | 2.13357300 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.13092716 |
| 65 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.11622366 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.11592366 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.10811750 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.10177195 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07635054 |
| 70 | Back pain (HP:0003418) | 2.07453782 |
| 71 | Polygenic inheritance (HP:0010982) | 2.06890997 |
| 72 | J-shaped sella turcica (HP:0002680) | 2.04690500 |
| 73 | Hypoglycemic coma (HP:0001325) | 2.04247589 |
| 74 | Cholelithiasis (HP:0001081) | 2.04167568 |
| 75 | Slow saccadic eye movements (HP:0000514) | 2.03322975 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.02700644 |
| 77 | Hypobetalipoproteinemia (HP:0003563) | 2.02238118 |
| 78 | Petechiae (HP:0000967) | 2.01950628 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.01945113 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.00931286 |
| 81 | Nuclear cataract (HP:0100018) | 2.00685950 |
| 82 | Emphysema (HP:0002097) | 2.00532803 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00320869 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.00320869 |
| 85 | Apathy (HP:0000741) | 2.00043457 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00021381 |
| 87 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99980987 |
| 88 | Glomerulonephritis (HP:0000099) | 1.99623947 |
| 89 | Difficulty running (HP:0009046) | 1.98473389 |
| 90 | Pseudobulbar signs (HP:0002200) | 1.98459353 |
| 91 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98083626 |
| 92 | Impaired platelet aggregation (HP:0003540) | 1.97887700 |
| 93 | Abnormal platelet function (HP:0011869) | 1.97887700 |
| 94 | Recurrent skin infections (HP:0001581) | 1.97679308 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.97430198 |
| 96 | Hypolipoproteinemia (HP:0010981) | 1.95067236 |
| 97 | Menorrhagia (HP:0000132) | 1.94138947 |
| 98 | Thin bony cortex (HP:0002753) | 1.93921863 |
| 99 | Diminished motivation (HP:0000745) | 1.93022474 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 1.91745971 |
| 101 | Optic neuritis (HP:0100653) | 1.91745971 |
| 102 | Epidermoid cyst (HP:0200040) | 1.91388216 |
| 103 | Muscle fiber splitting (HP:0003555) | 1.90701649 |
| 104 | Cardiomegaly (HP:0001640) | 1.89944002 |
| 105 | Esophageal varix (HP:0002040) | 1.89566772 |
| 106 | Myopathic facies (HP:0002058) | 1.89495682 |
| 107 | Mutism (HP:0002300) | 1.89384862 |
| 108 | Diastasis recti (HP:0001540) | 1.89069896 |
| 109 | Rapidly progressive (HP:0003678) | 1.88374508 |
| 110 | Peripheral hypomyelination (HP:0007182) | 1.88323189 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 1.88155795 |
| 112 | Gingival bleeding (HP:0000225) | 1.88007970 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.87846237 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87732361 |
| 115 | Bulbar palsy (HP:0001283) | 1.87545993 |
| 116 | Ankle clonus (HP:0011448) | 1.87479901 |
| 117 | Restrictive lung disease (HP:0002091) | 1.86942006 |
| 118 | Colitis (HP:0002583) | 1.85922530 |
| 119 | Vasculitis (HP:0002633) | 1.85215971 |
| 120 | Overgrowth (HP:0001548) | 1.85149970 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.85116195 |
| 122 | Lymphangioma (HP:0100764) | 1.85046558 |
| 123 | Hypercortisolism (HP:0001578) | 1.84462614 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.84096586 |
| 125 | Hyperacusis (HP:0010780) | 1.83098840 |
| 126 | Mitral valve prolapse (HP:0001634) | 1.82966161 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 1.82609850 |
| 128 | Urticaria (HP:0001025) | 1.82416221 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.82174794 |
| 130 | Disproportionate tall stature (HP:0001519) | 1.81424810 |
| 131 | Broad face (HP:0000283) | 1.80974626 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.80387174 |
| 133 | Recurrent viral infections (HP:0004429) | 1.79911310 |
| 134 | Abnormality of binocular vision (HP:0011514) | 1.79253144 |
| 135 | Diplopia (HP:0000651) | 1.79253144 |
| 136 | Conjunctival hamartoma (HP:0100780) | 1.77747467 |
| 137 | Hypochromic microcytic anemia (HP:0004840) | 1.76511569 |
| 138 | Prolonged partial thromboplastin time (HP:0003645) | 1.76405056 |
| 139 | Neurofibrillary tangles (HP:0002185) | 1.76275961 |
| 140 | Hypertriglyceridemia (HP:0002155) | 1.75288057 |
| 141 | Hamartoma of the eye (HP:0010568) | 1.75233114 |
| 142 | Right ventricular cardiomyopathy (HP:0011663) | 1.74548236 |
| 143 | Interstitial pulmonary disease (HP:0006530) | 1.74178257 |
| 144 | Abnormality of the thoracic spine (HP:0100711) | 1.74056507 |
| 145 | Global brain atrophy (HP:0002283) | 1.72962084 |
| 146 | Epistaxis (HP:0000421) | 1.72915240 |
| 147 | Abnormality of the nasal mucosa (HP:0000433) | 1.72634980 |
| 148 | Upper motor neuron abnormality (HP:0002127) | 1.72505771 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72051618 |
| 150 | Multiple lipomas (HP:0001012) | 1.71967401 |
| 151 | Hyperparathyroidism (HP:0000843) | 1.71657123 |
| 152 | Hyperbilirubinemia (HP:0002904) | 1.71134282 |
| 153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71076188 |
| 154 | Dementia (HP:0000726) | 1.70828105 |
| 155 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69803635 |
| 156 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69803635 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69803635 |
| 158 | Gastrointestinal inflammation (HP:0004386) | 1.69445985 |
| 159 | Increased CSF protein (HP:0002922) | 1.69290970 |
| 160 | Inflammation of the large intestine (HP:0002037) | 1.68869917 |
| 161 | Poikilocytosis (HP:0004447) | 1.68464032 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.66727334 |
| 163 | Upper limb amyotrophy (HP:0009129) | 1.65647994 |
| 164 | Distal upper limb amyotrophy (HP:0007149) | 1.65647994 |
| 165 | Neonatal onset (HP:0003623) | 1.63920274 |
| 166 | Increased serum ferritin (HP:0003281) | 1.63523038 |
| 167 | Hypochromic anemia (HP:0001931) | 1.62908414 |
| 168 | Aneurysm (HP:0002617) | 1.62682236 |
| 169 | EMG: neuropathic changes (HP:0003445) | 1.62386800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.36439900 |
| 2 | PRPF4B | 4.19665534 |
| 3 | PKN2 | 3.78955882 |
| 4 | MAP3K10 | 3.60614496 |
| 5 | ERN1 | 2.98348771 |
| 6 | RIPK1 | 2.51948168 |
| 7 | IRAK3 | 2.27605513 |
| 8 | MAP4K1 | 2.25099652 |
| 9 | SIK1 | 2.16338161 |
| 10 | EPHB1 | 2.14869863 |
| 11 | SMG1 | 2.13414930 |
| 12 | MAP3K13 | 1.85843382 |
| 13 | EEF2K | 1.83969393 |
| 14 | TAOK2 | 1.83788723 |
| 15 | PTK6 | 1.83568013 |
| 16 | GRK6 | 1.79956110 |
| 17 | SIK2 | 1.72200030 |
| 18 | TTN | 1.66316946 |
| 19 | ICK | 1.59437965 |
| 20 | DMPK | 1.57502049 |
| 21 | BMX | 1.55062053 |
| 22 | LRRK2 | 1.46638963 |
| 23 | FGFR4 | 1.44664549 |
| 24 | BLK | 1.44652069 |
| 25 | PRKD2 | 1.40444179 |
| 26 | TNK2 | 1.38283318 |
| 27 | HIPK2 | 1.34388052 |
| 28 | MAP3K3 | 1.33124670 |
| 29 | ALK | 1.31575065 |
| 30 | CDC42BPA | 1.26077822 |
| 31 | MAP3K14 | 1.24802320 |
| 32 | CSK | 1.22782338 |
| 33 | TAOK3 | 1.21912211 |
| 34 | PRKG2 | 1.21132392 |
| 35 | TYRO3 | 1.20232849 |
| 36 | TAOK1 | 1.20157633 |
| 37 | TGFBR2 | 1.18678667 |
| 38 | JAK2 | 1.11640529 |
| 39 | KSR2 | 1.11609885 |
| 40 | ARAF | 1.10741893 |
| 41 | SIK3 | 1.10148528 |
| 42 | MAP3K7 | 1.09178123 |
| 43 | STK10 | 1.08719660 |
| 44 | CDK12 | 1.06987868 |
| 45 | FES | 1.06764536 |
| 46 | TYK2 | 1.03182109 |
| 47 | TBK1 | 1.03035887 |
| 48 | BCKDK | 1.02800722 |
| 49 | PRKD1 | 1.02157119 |
| 50 | DYRK1B | 0.99194115 |
| 51 | MAP3K11 | 0.88996378 |
| 52 | PRKCH | 0.88850425 |
| 53 | PAK6 | 0.88206989 |
| 54 | RET | 0.87818003 |
| 55 | HCK | 0.84439775 |
| 56 | JAK3 | 0.84225845 |
| 57 | CSF1R | 0.82110180 |
| 58 | CDK6 | 0.80100162 |
| 59 | TESK2 | 0.78252955 |
| 60 | NME2 | 0.78086753 |
| 61 | UHMK1 | 0.76902017 |
| 62 | PDPK1 | 0.76610249 |
| 63 | DDR2 | 0.76313119 |
| 64 | PRKD3 | 0.76026282 |
| 65 | MAPK11 | 0.75164897 |
| 66 | DAPK2 | 0.74937681 |
| 67 | FGR | 0.74784358 |
| 68 | MARK2 | 0.73693202 |
| 69 | MOS | 0.73217030 |
| 70 | MAP3K1 | 0.71860537 |
| 71 | ZAP70 | 0.70717320 |
| 72 | RPS6KA2 | 0.69456580 |
| 73 | JAK1 | 0.68992376 |
| 74 | PDGFRA | 0.68674213 |
| 75 | CAMKK1 | 0.66836849 |
| 76 | IKBKE | 0.66064165 |
| 77 | TESK1 | 0.65579583 |
| 78 | ITK | 0.65512041 |
| 79 | ILK | 0.65487535 |
| 80 | BTK | 0.64998430 |
| 81 | CAMK1G | 0.64796624 |
| 82 | PDK1 | 0.63822003 |
| 83 | STK11 | 0.63602673 |
| 84 | MAP3K2 | 0.61748247 |
| 85 | MAPK7 | 0.61549074 |
| 86 | PHKG2 | 0.60634118 |
| 87 | PHKG1 | 0.60634118 |
| 88 | MAP2K3 | 0.60385856 |
| 89 | IRAK2 | 0.59045133 |
| 90 | STK38 | 0.58364339 |
| 91 | DAPK3 | 0.57863247 |
| 92 | RIPK4 | 0.57677008 |
| 93 | MAPK12 | 0.56837852 |
| 94 | WNK1 | 0.56143395 |
| 95 | MATK | 0.55010866 |
| 96 | CDK4 | 0.54997769 |
| 97 | CAMK1D | 0.54410775 |
| 98 | SGK3 | 0.51416202 |
| 99 | MAP3K9 | 0.51378382 |
| 100 | BRAF | 0.50958343 |
| 101 | TLK1 | 0.50528096 |
| 102 | IRAK1 | 0.50136033 |
| 103 | SYK | 0.49995937 |
| 104 | GSK3A | 0.49769949 |
| 105 | IKBKB | 0.49762272 |
| 106 | CAMK4 | 0.49245294 |
| 107 | RPS6KA6 | 0.49125767 |
| 108 | PDGFRB | 0.48637627 |
| 109 | RPS6KA1 | 0.48523252 |
| 110 | MAP2K2 | 0.48229124 |
| 111 | MTOR | 0.48211960 |
| 112 | LYN | 0.47534374 |
| 113 | CLK1 | 0.47034060 |
| 114 | MARK3 | 0.45282844 |
| 115 | FGFR3 | 0.45166700 |
| 116 | MAP3K6 | 0.44076138 |
| 117 | PAK4 | 0.43235793 |
| 118 | MAPK4 | 0.43028770 |
| 119 | NEK9 | 0.42836595 |
| 120 | LMTK2 | 0.40541460 |
| 121 | RPS6KC1 | 0.39239316 |
| 122 | RPS6KL1 | 0.39239316 |
| 123 | MAP2K6 | 0.38966971 |
| 124 | PRKCQ | 0.36380514 |
| 125 | LCK | 0.36059591 |
| 126 | IRAK4 | 0.35637383 |
| 127 | EPHA3 | 0.33939858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.49139989 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45347329 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.98603642 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71566023 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.66549312 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23322924 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02387215 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02257924 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95005714 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.87909843 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74202839 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.72102225 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.70299401 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61577573 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60906434 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.58026688 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50055836 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.40430798 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38642597 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.35212491 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34127726 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31699140 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30547150 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28555679 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26387890 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21191011 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20398477 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19042525 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16015797 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14906821 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13160215 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10745331 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10223361 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.08631290 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.07960552 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06961494 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.06774572 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06143884 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04939293 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04648607 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03099347 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03089220 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.01808772 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.01060763 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00259505 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99775367 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99532176 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96894784 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95454436 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94609317 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94560520 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.94534132 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.91371059 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91143099 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90000058 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89850445 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.89210627 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89059005 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.88934092 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88449455 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87579705 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.86672864 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86606668 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85406685 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84290696 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84271053 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84006161 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82735989 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.81901334 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.81668245 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80544767 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80530629 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80275989 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.80249246 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80019114 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79729218 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79675725 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78705075 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78061335 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77724966 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76379779 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76307816 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76033523 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74942024 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74644921 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73611146 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73346379 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72211701 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71745800 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71261499 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70308019 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70125795 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70096314 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69299614 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66993711 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66020968 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.65924709 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65339288 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.65028092 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65023993 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64850926 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.64738472 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64594288 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.64532330 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64216065 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63773914 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63765825 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.63761200 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63739224 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63665428 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63440896 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63383253 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62216804 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62003863 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61595717 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61192805 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60634047 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.60173026 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58484988 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58092933 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56898215 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56276314 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.55881722 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55437667 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.55234337 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52825334 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52745785 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52597887 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52168554 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50683117 |
| 131 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50514408 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50294755 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50194975 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48618316 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48574097 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47515677 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47453009 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47191116 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47082611 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.47068660 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46889138 |
| 142 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46615429 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44004802 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42826061 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42583240 |
| 146 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41897340 |
| 147 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41617902 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.40127849 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39515408 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39496309 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38225934 |
| 152 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37975396 |
| 153 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37837210 |

